Analysis for Anavex Life Sciences Corp. (AVXL)

Add AVXL to watchlist(s)

You Should Create a Watchlist In The First Place.

Price Over Time

Profile

Company Name

Anavex Life Sciences Corp.

Symbol

AVXL

Currency

USD

Exchange

Nasdaq

Head Quarter

United States, New York

Sector

Healthcare

Industry

Biotechnology

Website

https://www.anavex.com

ISIN

US0327973006

CIK

1314052

CUSIP

032797300

UEI

-

LEI

-

Business Description

Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease;